학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 19건 | 목록 10~20
Academic Journal
de Vries NL; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands.; van de Haar J; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Veninga V; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Chalabi M; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Gastrointestinal Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Ijsselsteijn ME; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; van der Ploeg M; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; van den Bulk J; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; Ruano D; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; van den Berg JG; Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Haanen JB; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Zeverijn LJ; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Geurts BS; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; de Wit GF; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Battaglia TW; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.; Verheul HMW; Department of Medical Oncology, Erasmus MC, Rotterdam, The Netherlands.; Schumacher TN; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.; Wessels LFA; Oncode Institute, Utrecht, The Netherlands.; Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Faculty of EEMCS, Delft University of Technology, Delft, The Netherlands.; Koning F; Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands.; de Miranda NFCC; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands. n.f.de_miranda@lumc.nl.; Voest EE; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands. e.voest@nki.nl.; Oncode Institute, Utrecht, The Netherlands. e.voest@nki.nl.
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE
Academic Journal
Schipper LJ; Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Zeverijn LJ; Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Garnett MJ; Wellcome Sanger Institute, Cambridge, United Kingdom.; Voest EE; Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE
Academic Journal
van Berge Henegouwen JM; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands; Oncode Institute, the Netherlands.; Jebbink M; Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Hoes LR; Oncode Institute, the Netherlands; Department of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; van der Wijngaart H; Oncode Institute, the Netherlands; Department of Medical Oncology, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands.; Zeverijn LJ; Oncode Institute, the Netherlands; Department of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; van der Velden DL; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Center, Amsterdam, the Netherlands.; Roepman P; Hartwig Medical Foundation, Amsterdam, the Netherlands.; de Leng WWJ; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.; Jansen AML; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.; van Werkhoven E; Biometrics Department, Netherlands Cancer Institute, Amsterdam, the Netherlands.; van der Noort V; Biometrics Department, Netherlands Cancer Institute, Amsterdam, the Netherlands.; van der Wekken AJ; Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.; de Langen AJ; Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Voest EE; Oncode Institute, the Netherlands; Department of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Verheul HMW; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.; Smit EF; Department of Pulmonology, Leiden University Medical Center, Leiden, the Netherlands.; Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: a.j.gelderblom@lumc.nl.
Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
Academic Journal
van Berge Henegouwen JM; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.; van der Wijngaart H; Department of Medical Oncology, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Zeverijn LJ; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Hoes LR; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Meertens M; Department of Pharmacy and Pharmacology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Huitema ADR; Department of Pharmacy and Pharmacology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Pharmacology, Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands.; Devriese LA; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.; Labots M; Department of Medical Oncology, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Verheul HMW; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.; Voest EE; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands. A.J.Gelderblom@lumc.nl.
Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE
Editorial & Opinion
van Waalwijk van Doorn-Khosrovani SB; CZ Health Insurance, Tilburg, Netherlands.; Zeverijn LJ; Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, 1066 CX, Amsterdam, Netherlands; Oncode Institute, Utrecht, Netherlands.; Voest EE; Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, 1066 CX, Amsterdam, Netherlands; Oncode Institute, Utrecht, Netherlands. Electronic address: e.voest@nki.nl.
Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE
Academic Journal
Hoes LR; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute Amsterdam, the Netherlands.; Oncode Institute, the Netherlands Cancer Institute, Amsterdam, the Netherlands.; van Berge Henegouwen JM; Oncode Institute, the Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.; van der Wijngaart H; Oncode Institute, the Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Medical Oncology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands.; Zeverijn LJ; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute Amsterdam, the Netherlands.; Oncode Institute, the Netherlands Cancer Institute, Amsterdam, the Netherlands.; van der Velden DL; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute Amsterdam, the Netherlands.; van de Haar J; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute Amsterdam, the Netherlands.; Oncode Institute, the Netherlands Cancer Institute, Amsterdam, the Netherlands.; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Roepman P; Hartwig Medical Foundation, Amsterdam, the Netherlands.; de Leng WJ; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.; Jansen AML; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.; van Werkhoven E; Biometrics Department, Netherlands Cancer Institute, Amsterdam, the Netherlands.; van der Noort V; Biometrics Department, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Huitema ADR; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.; Department of Pharmacy & Pharmacology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Pharmacology, Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Gort EH; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, the Netherlands.; de Groot JWB; Isala Oncology Center, Isala, Zwolle, the Netherlands.; Kerver ED; Department of Medical Oncology, Onze Lieve Vrouwe Gasthuis, Amsterdam, the Netherlands.; de Groot DJ; Medical Oncology, University Medical Centre Groningen, Groningen, the Netherlands.; Erdkamp F; Department of Medical Oncology, Zuyderland Hospital, Sittard-Geleen, the Netherlands.; Beerepoot LV; Department of Medical Oncology, Elisabeth-Tweesteden Hospital, Tilburg, the Netherlands.; Hendriks MP; Department of Medical Oncology, Northwest Clinics, the Netherlands.; Smit EF; Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; van der Graaf WTA; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; van Herpen CML; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.; Labots M; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.; Hoeben A; Division of Medical Oncology, Department of Internal Medicine, GROW-School of Oncology and Developmental Biology, Maastricht University Medical Center, the Netherlands.; Morreau H; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands.; Lolkema MP; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands.; Center for Personalized Cancer Treatment, Rotterdam, the Netherlands.; Cuppen E; Oncode Institute, the Netherlands Cancer Institute, Amsterdam, the Netherlands.; Hartwig Medical Foundation, Amsterdam, the Netherlands.; Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, the Netherlands.; Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.; Verheul HMW; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.; Voest EE; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute Amsterdam, the Netherlands.; Oncode Institute, the Netherlands Cancer Institute, Amsterdam, the Netherlands.; Center for Personalized Cancer Treatment, Rotterdam, the Netherlands.
Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
Zeverijn LJ; Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, 1066 CX Amsterdam, Netherlands; Oncode Institute, Utrecht, Netherlands.; van Waalwijk van Doorn-Khosrovani SB; CZ Health Insurance, Tilburg, Netherlands.; van Roy AAMGP; CZ Health Insurance, Tilburg, Netherlands.; Timmers L; National Health Care Institute (Zorginstituut Nederland), Diemen, Netherlands.; Ly Tran TH; National Health Care Institute (Zorginstituut Nederland), Diemen, Netherlands.; de Boer JE; National Health Care Institute (Zorginstituut Nederland), Diemen, Netherlands.; de Wit GF; Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, 1066 CX Amsterdam, Netherlands; Oncode Institute, Utrecht, Netherlands.; Geurts BS; Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, 1066 CX Amsterdam, Netherlands; Oncode Institute, Utrecht, Netherlands.; Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, Netherlands.; Verheul HMW; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, Netherlands.; Blijlevens N; Department of Hematology, Radboud University Medical Center, Nijmegen, Netherlands.; Wymenga ANM; Department of Medical Oncology, Medical Spectrum Twente, Enschede, Netherlands.; Eskens FALM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, Netherlands.; Smit EF; Department of Thoracic Oncology, Netherlands Cancer Institute, 1066 CX Amsterdam, Netherlands; Department of Pulmonary Diseases, Leiden University Medical Center, Leiden, Netherlands.; Bloemendal HJ; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, Netherlands.; Voest EE; Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, 1066 CX Amsterdam, Netherlands; Oncode Institute, Utrecht, Netherlands. Electronic address: e.voest@nki.nl.
Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE
Academic Journal
van der Wijngaart H; Department of Medical Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Hoes LR; Oncode Institute, Utrecht, the Netherlands.; Department of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; van Berge Henegouwen JM; Oncode Institute, Utrecht, the Netherlands.; Department of Medical Oncology, Leiden University Medical Center, Rapenburg, Leiden, the Netherlands.; van der Velden DL; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.; Zeverijn LJ; Oncode Institute, Utrecht, the Netherlands.; Department of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Roepman P; Hartwig Medical Foundation, Amsterdam, the Netherlands.; van Werkhoven E; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, the Netherlands.; de Leng WWJ; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.; Jansen AML; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.; Mehra N; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.; Robbrecht DGJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Labots M; Department of Medical Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.; de Groot DJA; Department of Medical Oncology, University Medical Center Groningen, Groningen, the Netherlands.; Hoeben A; Department of Medical Oncology, Maastricht University Medical Center, Maastricht, the Netherlands.; Hamberg P; Department of Internal Medicine, Franciscus Gasthuis and Vlietland, Rotterdam, the Netherlands.; Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Rapenburg, Leiden, the Netherlands.; Voest EE; Oncode Institute, Utrecht, the Netherlands.; Department of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Verheul HMW; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands. henk.verheul@radboudumc.nl.
Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
Bokslag A; Department of Obstetrics and Gynaecology, Amsterdam UMC, Vrije Universiteit Amsterdam , Amsterdam, The Netherlands.; Fons AB; Department of Obstetrics and Gynaecology, Amsterdam UMC, Vrije Universiteit Amsterdam , Amsterdam, The Netherlands.; Zeverijn LJ; Department of Obstetrics and Gynaecology, Amsterdam UMC, Vrije Universiteit Amsterdam , Amsterdam, The Netherlands.; Teunissen PW; Department of Obstetrics and Gynaecology, Amsterdam UMC, Vrije Universiteit Amsterdam , Amsterdam, The Netherlands.; School of Health Professions Education (SHE), Maastricht University , Maastricht, The Netherlands.; de Groot CJM; Department of Obstetrics and Gynaecology, Amsterdam UMC, Vrije Universiteit Amsterdam , Amsterdam, The Netherlands.
Publisher: Informa Healthcare Country of Publication: England NLM ID: 9421297 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-6065 (Electronic) Linking ISSN: 10641955 NLM ISO Abbreviation: Hypertens Pregnancy Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Zeverijn LJ
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어